Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Leung

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Journal of Medical Imaging and Radiation Sciences|July 19, 2022
An observational study evaluating the impact on prostate patient outcomes and experiences when radiation therapists use a standard grading system tool to assess and document treatment-related toxicities and interventionsEdward Leung, Heather Fineberg, Tessa Larsen, et al.
The Journal of Biological Chemistry|March 19, 2005
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cellsStefania Merighi, Annalisa Benini, Prisco Mirandola, et al.
Biochemical Pharmacology|May 10, 2006
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cellsStefania Merighi, Annalisa Benini, Prisco Mirandola, et al.
Biochemical Pharmacology|October 16, 2007
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviourStefania Gessi, Eleonora Fogli, Valeria Sacchetto, et al.
Molecular Pharmacology|January 26, 2002
A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical studyStefania Gessi, Katia Varani, Stefania Merighi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 17, 2009
Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cellsStefania Gessi, Eleonora Fogli, Valeria Sacchetto, et al.
Journal of the American Chemical Society|July 1, 2015
Transition State Features in the Hepatitis Delta Virus Ribozyme Reaction Revealed by Atomic PerturbationsSelene C Koo, Jun Lu, Nan-Sheng Li, et al.
Pharmacology & Therapeutics|October 11, 2003
A glance at adenosine receptors: novel target for antitumor therapyStefania Merighi, Prisco Mirandola, Katia Varani, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2005
Synthesis and biological characterization of [3H] (2-amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)-(4-chlorophenyl)-methanone, the first radiolabelled adenosine A1 allosteric enhancerPier Giovanni Baraldi, Maria Giovanna Pavani, Edward Leung, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 5, 2008
LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson's disease compared to late-onset patientsDaniel Kam Yin Chan, Ping Wing Ng, Vincent Mok, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Journal of Medical Imaging and Radiation Sciences|July 19, 2022
An observational study evaluating the impact on prostate patient outcomes and experiences when radiation therapists use a standard grading system tool to assess and document treatment-related toxicities and interventionsEdward Leung, Heather Fineberg, Tessa Larsen, et al.
The Journal of Biological Chemistry|March 19, 2005
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cellsStefania Merighi, Annalisa Benini, Prisco Mirandola, et al.
Biochemical Pharmacology|May 10, 2006
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cellsStefania Merighi, Annalisa Benini, Prisco Mirandola, et al.
Biochemical Pharmacology|October 16, 2007
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviourStefania Gessi, Eleonora Fogli, Valeria Sacchetto, et al.
Molecular Pharmacology|January 26, 2002
A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical studyStefania Gessi, Katia Varani, Stefania Merighi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 17, 2009
Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cellsStefania Gessi, Eleonora Fogli, Valeria Sacchetto, et al.
Journal of the American Chemical Society|July 1, 2015
Transition State Features in the Hepatitis Delta Virus Ribozyme Reaction Revealed by Atomic PerturbationsSelene C Koo, Jun Lu, Nan-Sheng Li, et al.
Pharmacology & Therapeutics|October 11, 2003
A glance at adenosine receptors: novel target for antitumor therapyStefania Merighi, Prisco Mirandola, Katia Varani, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2005
Synthesis and biological characterization of [3H] (2-amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)-(4-chlorophenyl)-methanone, the first radiolabelled adenosine A1 allosteric enhancerPier Giovanni Baraldi, Maria Giovanna Pavani, Edward Leung, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 5, 2008
LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson's disease compared to late-onset patientsDaniel Kam Yin Chan, Ping Wing Ng, Vincent Mok, et al.
Pageof 6